Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kang, Min-Jung | - |
dc.contributor.author | Hwang, Yong Hee | - |
dc.contributor.author | Lee, Won | - |
dc.contributor.author | Kim, Dong-Hyun | - |
dc.date.accessioned | 2024-01-21T01:35:27Z | - |
dc.date.available | 2024-01-21T01:35:27Z | - |
dc.date.created | 2021-09-05 | - |
dc.date.issued | 2007-01 | - |
dc.identifier.issn | 0951-4198 | - |
dc.identifier.uri | https://pubs.kist.re.kr/handle/201004/134768 | - |
dc.description.abstract | Electrospray ionization (ESI) mass spectra of 15 anti-estrogenic substances, beta 2-agonists and mesocarb were investigated in terms of fragmentation patterns. On the basis of this product ion information, a simultaneous screening method for anti-estrogenic substances, beta 2-agonists and mesocarb was developed for doping control purposes. After hydrolysis, liquid-liquid extraction was adopted for the sample preparation. The recoveries for all compounds were 30 and 96%. A single liquid chromatography/tandem mass spectrometry (LC/MS/MS) analysis could be performed in 13 min for the analysis of 15 anti-estrogenic substances, beta 2-agonists and mesocarb. A quantitative analysis was also validated. Inaccuracies were below +/- 12% and precisions varied from 0 to 15.8%. The limit of detection was below 10 ng/mL except formestane (300 ng/mL) and aminoglutethimide (100 ng/mL). The validated method was applied for the analysis of excretion samples. Copyright (c) 2006 John Wiley & Sons, Ltd. | - |
dc.language | English | - |
dc.publisher | John Wiley & Sons Inc. | - |
dc.title | Validation and application of a screening method for beta 2-agonists, anti-estrogenic substances and mesocarb in human urine using liquid chromatography/tandem mass spectrometry | - |
dc.type | Article | - |
dc.identifier.doi | 10.1002/rcm.2834 | - |
dc.description.journalClass | 1 | - |
dc.identifier.bibliographicCitation | Rapid Communications in Mass Spectrometry, v.21, no.2, pp.252 - 264 | - |
dc.citation.title | Rapid Communications in Mass Spectrometry | - |
dc.citation.volume | 21 | - |
dc.citation.number | 2 | - |
dc.citation.startPage | 252 | - |
dc.citation.endPage | 264 | - |
dc.description.isOpenAccess | N | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.identifier.wosid | 000243473500021 | - |
dc.identifier.scopusid | 2-s2.0-33846204287 | - |
dc.relation.journalWebOfScienceCategory | Biochemical Research Methods | - |
dc.relation.journalWebOfScienceCategory | Chemistry, Analytical | - |
dc.relation.journalWebOfScienceCategory | Spectroscopy | - |
dc.relation.journalResearchArea | Biochemistry & Molecular Biology | - |
dc.relation.journalResearchArea | Chemistry | - |
dc.relation.journalResearchArea | Spectroscopy | - |
dc.type.docType | Article | - |
dc.subject.keywordPlus | AROMATASE INHIBITOR | - |
dc.subject.keywordPlus | QUANTITATIVE-ANALYSIS | - |
dc.subject.keywordPlus | BETA-AGONISTS | - |
dc.subject.keywordPlus | IDENTIFICATION | - |
dc.subject.keywordPlus | CLENBUTEROL | - |
dc.subject.keywordPlus | EXEMESTANE | - |
dc.subject.keywordPlus | EXTRACTION | - |
dc.subject.keywordPlus | CIMATEROL | - |
dc.subject.keywordPlus | PLASMA | - |
dc.subject.keywordPlus | ONLINE | - |
dc.subject.keywordAuthor | screening method | - |
dc.subject.keywordAuthor | anti-estrogenic substances | - |
dc.subject.keywordAuthor | b2-agonists | - |
dc.subject.keywordAuthor | mesorcarb | - |
dc.subject.keywordAuthor | LC-MS | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.